Awardee OrganizationUNIVERSITY OF TENNESSEE HEALTH SCI CTR
Description
Abstract Text
DESCRIPTION (provided by applicant): Prenatal substance exposure continues to be a major public health problem that affects millions of children and places enormous financial and social burdens on society. Little is known about the effects of prenatal cocaine exposure on psychological, developmental, medical or physical outcomes in children entering adolescence. The Maternal Lifestyle Study (MLS) is an interagency collaboration involving the National Institute of Child Health and Human Development and the National Institute on Drug Abuse. MLS is being conducted in four academic centers: The University of Miami, University of Tennessee at Memphis, Wayne State University and Brown University. MLS is the largest clinical prospective longitudinal study to date of prenatal drug exposure and child outcome. The follow-up cohort includes 658 exposed and 730 comparison children who have been studied through 9 years of age with 75% retention. The MLS study involves a unique population given its multi-site component, racial diversity, and extensive long-term follow up. One aim is to determine if prenatal cocaine or other prenatal drug exposure results in adverse psychological and developmental outcomes at 12-15 years. These outcomes include substance use (early substance use onset, smoking, alcohol consumption and substance abuse and addiction), academic and cognitive deficits (e.g., poor school performance), physiological reactivity, antisocial behavior (e.g. delinquency), psychopathology, risk taking behavior (e.g., adolescent pregnancy, sexually transmitted diseases). The role of protective factors such as positive parenting and peer relationships will also be investigated. A second aim is to determine the effects of prenatal cocaine exposure on physical and medical outcomes at 12-15 years. These outcomes include physical growth and medical illness, including hypertension, obesity and metabolic disorder, which may have their origins in fetal life, and may be related the impact of drug exposure on fetal growth. Additional outcomes include structural teratogenic effects (dysmorphology), and neurological disorders. In addition to being a study of prenatal cocaine exposure, MLS is also a study of children growing up in adverse conditions, providing information on development in typically developing children and children at risk. A thorough understanding of the consequences of prenatal cocaine exposure and associated maternal lifestyles is necessary to the development of treatment and public policy initiatives.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdolescenceAdolescentAdultAffectAgeAge-YearsAlcohol consumptionAlcohol or Other Drugs useAlcoholsBarker HypothesisBehaviorBehavioralBirthBirth OrderBirth WeightBlood PressureBlood VesselsChildChildhoodClinicalClinical ResearchCocaineCognitive deficitsCollaborationsConditionDevelopmentDiseaseDrug ExposureDrug abuseDysmorphologyEmotionalEmotionsEnvironmentEnvironmental Risk FactorExposure toFamilyFetal Cocaine ExposureFetal GrowthGenderGoalsGrowthHome environmentHypertensionInstitutesIntakeLeadLifeLife StyleLong-Term EffectsLongitudinal StudiesMarijuanaMediator of activation proteinMedicalMetabolic DiseasesMinorityModelingNational Institute of Child Health and Human DevelopmentNutritionalObesityOpiatesOutcomeParenting behaviorParentsParticipantPathway interactionsPerformancePharmaceutical PreparationsPhasePhysical activityPhysiologicalPlacementPopulationPregnancyPregnancy in AdolescenceProtocols documentationPsychopathologyPsychosocial FactorPublic HealthPublic PolicyPublishingPurposeRangeRateResearchResearch PersonnelRiskRisk-TakingRoleSchoolsSexual MaturationSexually Transmitted DiseasesSiteSmokingSocietiesSodiumSubstance abuse problemTennesseeTeratologyTestingTobaccoU-Series Cooperative AgreementsUniversitiesViolenceWorkYouthaddictionanti socialbasecaregivingcohortdesigndrug exposure in uteroearly onset substance usefetalfetal drug exposurefollow-uphigh risk behaviorin uteronervous system disorderobesity riskparitypeerprenatalprogramsprospectivepsychologicresponsesizesocialtherapy development
No Sub Projects information available for 9U10DA024128-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 9U10DA024128-06
Patents
No Patents information available for 9U10DA024128-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 9U10DA024128-06
Clinical Studies
No Clinical Studies information available for 9U10DA024128-06
News and More
Related News Releases
No news release information available for 9U10DA024128-06
History
No Historical information available for 9U10DA024128-06
Similar Projects
No Similar Projects information available for 9U10DA024128-06